Bruker Corp. (BRKR)
61.56
+1.23
(+2.04%)
USD |
NASDAQ |
Nov 13, 16:00
61.56
0.00 (0.00%)
After-Hours: 16:59
Bruker Net Income (Quarterly) : -109.70M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -109.70M |
| June 30, 2026 | -50.90M |
| March 31, 2026 | 15.70M |
| December 31, 2025 | 29.20M |
| September 30, 2025 | -58.50M |
| June 30, 2025 | 4.20M |
| March 31, 2025 | 16.80M |
| December 31, 2024 | 13.90M |
| September 30, 2024 | 40.30M |
| June 30, 2024 | 7.60M |
| March 31, 2024 | 52.00M |
| December 31, 2023 | 204.60M |
| September 30, 2023 | 88.70M |
| June 30, 2023 | 57.80M |
| March 31, 2023 | 77.40M |
| December 31, 2022 | 98.30M |
| September 30, 2022 | 88.40M |
| June 30, 2022 | 49.70M |
| March 31, 2022 | 62.10M |
| December 31, 2021 | 76.00M |
| September 30, 2021 | 88.10M |
| June 30, 2021 | 58.70M |
| March 31, 2021 | 57.80M |
| December 31, 2020 | 71.30M |
| September 30, 2020 | 55.30M |
| Date | Value |
|---|---|
| June 30, 2020 | 24.20M |
| March 31, 2020 | 10.60M |
| December 31, 2019 | 68.80M |
| September 30, 2019 | 61.50M |
| June 30, 2019 | 37.00M |
| March 31, 2019 | 30.70M |
| December 31, 2018 | 77.90M |
| September 30, 2018 | 44.20M |
| June 30, 2018 | 31.50M |
| March 31, 2018 | 27.40M |
| December 31, 2017 | -3.00M |
| September 30, 2017 | 37.60M |
| June 30, 2017 | 24.00M |
| March 31, 2017 | 21.70M |
| December 31, 2016 | 69.10M |
| September 30, 2016 | 47.00M |
| June 30, 2016 | 14.80M |
| March 31, 2016 | 23.60M |
| December 31, 2015 | 62.00M |
| September 30, 2015 | 12.90M |
| June 30, 2015 | 23.10M |
| March 31, 2015 | 6.90M |
| December 31, 2014 | 26.50M |
| September 30, 2014 | 6.30M |
| June 30, 2014 | 16.80M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 362.00M |
| Danaher Corp. | 1.207B |
| Thermo Fisher Scientific, Inc. | 1.727B |
| Bio-Rad Laboratories, Inc. | 458.60M |
| Harvard Bioscience, Inc. | -2.623M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 874.00M |
| Total Expenses (Quarterly) | 985.80M |
| EPS Diluted (Quarterly) | -0.8052 |
| Enterprise Value | 10.82B |
| Gross Profit Margin (Quarterly) | 49.19% |
| Profit Margin (Quarterly) | -12.55% |
| Earnings Yield | -1.78% |
| Operating Earnings Yield | 3.77% |
| Normalized Earnings Yield | 1.158 |